VEGF-D

VEGF-D 詳細

英語名Vascular endothelial growth factor D市販薬剤の数0
治験薬の数2ターゲットの別称C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D),FIGF,c-Fos-induced growth factor,VEGFD,VEGF-D,Vascular Endothelial Growth Factor D
研究&開発段階Phase 2 Clinical
英語名Vascular endothelial growth factor D
ターゲットの別称C-Fos Induced Growth Factor (Vascular Endothelial Growth Factor D),FIGF,c-Fos-induced growth factor,VEGFD,VEGF-D,Vascular Endothelial Growth Factor D
市販薬剤の数0
治験薬の数2
研究&開発段階Phase 2 Clinical

VEGF-D 製品リスト

  • 属性

    Protein (5)

  • 製品ライブラリ

    オンライン (5)

  • Human (2)Cynomolgus (1)Mouse (2)

  • タグ

    His Tag (2)His Tag & Avi Tag (2)Fc Tag (1)

  • マーカー

    Unconjugated (3)Biotin-labeled (2)

VEGF-Dバックグランド

Vascular endothelial growth factor D (VEGF-D) is also known as C-fos induced growth factor (FIGF), which belongs to the PDGF / VEGF growth factor family and is active in angiogenesis, lymphangiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. This secreted protein VEGF-D / FIGF undergoes a complex proteolytic maturation, generating multiple processed forms that bind and activate VEGFR-2 and VEGFR-3. The structure and function of this protein is similar to those of VEGFC. FIGF / VEGF-D is highly expressed in lung, heart, small intestine and fetal lung. FIGF / VEGF-D may function in the formation of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR / FLK1) and VEGFR-3 (FLT4) receptors.

VEGF-D分子の別称

FIGF,VEGFD

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
EG-016EG-016; Ad-VEGF-APhase 2 ClinicalArk Therapeutics LtdPeripheral Vascular Diseases
詳細
EG-011EG-011; Ad-VEGF-DPhase 2 ClinicalArk Therapeutics LtdAngina Pectoris
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8